Multimodality imaging of bone marrow involvement in paediatric oncology

Identifying bone marrow involvement (with or without bone destruction) in children with cancer is essential for adequate diagnosis, prognostication, therapy planning, and response assessment. Imaging plays an increasing role, with MRI including DWI and [18F]FDG-PET/CT as the most commonly used imagi...

Full description

Saved in:
Bibliographic Details
Main Authors: Rutger A.J. Nievelstein, Lise Borgwardt, Thekla von Kalle, Annemieke S. Littooij, Lil-Sofie Ording Müller, Nelleke Tolboom
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:EJC Paediatric Oncology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2772610X2400045X
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846124943714025472
author Rutger A.J. Nievelstein
Lise Borgwardt
Thekla von Kalle
Annemieke S. Littooij
Lil-Sofie Ording Müller
Nelleke Tolboom
author_facet Rutger A.J. Nievelstein
Lise Borgwardt
Thekla von Kalle
Annemieke S. Littooij
Lil-Sofie Ording Müller
Nelleke Tolboom
author_sort Rutger A.J. Nievelstein
collection DOAJ
description Identifying bone marrow involvement (with or without bone destruction) in children with cancer is essential for adequate diagnosis, prognostication, therapy planning, and response assessment. Imaging plays an increasing role, with MRI including DWI and [18F]FDG-PET/CT as the most commonly used imaging techniques. Interpretation of the paediatric bone marrow on imaging might be challenging because of age-related physiological changes in the bone marrow, as well as disease and therapy related effects. In this review, we discuss how the imaging techniques available may be employed to detect bone marrow involvement (BMI) in paediatric oncology. Furthermore, insights into physiological, disease and therapy related bone marrow changes in children that might influence bone marrow imaging interpretation will be provided.
format Article
id doaj-art-4cc8b87f6b604a1bbc247dc3eeba2404
institution Kabale University
issn 2772-610X
language English
publishDate 2024-12-01
publisher Elsevier
record_format Article
series EJC Paediatric Oncology
spelling doaj-art-4cc8b87f6b604a1bbc247dc3eeba24042024-12-13T11:08:30ZengElsevierEJC Paediatric Oncology2772-610X2024-12-014100185Multimodality imaging of bone marrow involvement in paediatric oncologyRutger A.J. Nievelstein0Lise Borgwardt1Thekla von Kalle2Annemieke S. Littooij3Lil-Sofie Ording Müller4Nelleke Tolboom5Department of Radiology & Nuclear Medicine, UMC Utrecht/Wilhelmina Children’s Hospital, and Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Correspondence to: Department of Radiology & Nuclear Medicine, Division Imaging & Oncology, UMC Utrecht/Wilhelmina Children’s Hospital, P.O. Box 85500, Utrecht, GA 3508, the Netherlands.Department of Clinical Physiology and Nuclear medicine, Copenhagen University Hospital, Rigshospitalet, Copenhagen, DenmarkRadiological Institute Olgahospital, Klinikum Stuttgart, Stuttgart, GermanyDepartment of Radiology & Nuclear Medicine, UMC Utrecht/Wilhelmina Children’s Hospital, and Princess Máxima Center for Pediatric Oncology, Utrecht, the NetherlandsDivision of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, NorwayDepartment of Radiology & Nuclear Medicine, UMC Utrecht/Wilhelmina Children’s Hospital, and Princess Máxima Center for Pediatric Oncology, Utrecht, the NetherlandsIdentifying bone marrow involvement (with or without bone destruction) in children with cancer is essential for adequate diagnosis, prognostication, therapy planning, and response assessment. Imaging plays an increasing role, with MRI including DWI and [18F]FDG-PET/CT as the most commonly used imaging techniques. Interpretation of the paediatric bone marrow on imaging might be challenging because of age-related physiological changes in the bone marrow, as well as disease and therapy related effects. In this review, we discuss how the imaging techniques available may be employed to detect bone marrow involvement (BMI) in paediatric oncology. Furthermore, insights into physiological, disease and therapy related bone marrow changes in children that might influence bone marrow imaging interpretation will be provided.http://www.sciencedirect.com/science/article/pii/S2772610X2400045XMultimodality imagingPaediatric radiologyMRIPETBone marrowBone marrow involvement
spellingShingle Rutger A.J. Nievelstein
Lise Borgwardt
Thekla von Kalle
Annemieke S. Littooij
Lil-Sofie Ording Müller
Nelleke Tolboom
Multimodality imaging of bone marrow involvement in paediatric oncology
EJC Paediatric Oncology
Multimodality imaging
Paediatric radiology
MRI
PET
Bone marrow
Bone marrow involvement
title Multimodality imaging of bone marrow involvement in paediatric oncology
title_full Multimodality imaging of bone marrow involvement in paediatric oncology
title_fullStr Multimodality imaging of bone marrow involvement in paediatric oncology
title_full_unstemmed Multimodality imaging of bone marrow involvement in paediatric oncology
title_short Multimodality imaging of bone marrow involvement in paediatric oncology
title_sort multimodality imaging of bone marrow involvement in paediatric oncology
topic Multimodality imaging
Paediatric radiology
MRI
PET
Bone marrow
Bone marrow involvement
url http://www.sciencedirect.com/science/article/pii/S2772610X2400045X
work_keys_str_mv AT rutgerajnievelstein multimodalityimagingofbonemarrowinvolvementinpaediatriconcology
AT liseborgwardt multimodalityimagingofbonemarrowinvolvementinpaediatriconcology
AT theklavonkalle multimodalityimagingofbonemarrowinvolvementinpaediatriconcology
AT annemiekeslittooij multimodalityimagingofbonemarrowinvolvementinpaediatriconcology
AT lilsofieordingmuller multimodalityimagingofbonemarrowinvolvementinpaediatriconcology
AT nelleketolboom multimodalityimagingofbonemarrowinvolvementinpaediatriconcology